Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia

Currently, no standard of care exists for the treatment of relapsed or refractory acute myeloid leukemia (AML). We present our institutional experience with using either CLAG-M or HAM-pegA, a novel regimen that includes pegaspargase. This is a retrospective comparison of 34 patients receiving CLAG-M...

Descripción completa

Detalles Bibliográficos
Autores principales: Patzke, Ciera L., Duffy, Alison P., Duong, Vu H., El Chaer, Firas, Trovato, James A., Baer, Maria R., Bentzen, Søren M., Emadi, Ashkan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074083/
https://www.ncbi.nlm.nih.gov/pubmed/32079074
http://dx.doi.org/10.3390/jcm9020536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074083/
https://www.ncbi.nlm.nih.gov/pubmed/32079074
http://dx.doi.org/10.3390/jcm9020536

Ejemplares similares